The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sopharma AD notifies that for October 2015 the Company recorded same level of sales revenues compared to the same month of 2014, including 2% increase of domestic sales and 2% decrease of export sales.
For the first ten months of this year, revenues from sales decreased by 16% compared to the same period of 2014, including 2% increase of domestic sales and a 25% decrease of export sales.
Sopharma AD notifies that for November 2015 the Company recorded a decrease of sales revenues of 5% compared to the same month of 2014, including 3% increase of domestic sales and 9% decrease of export sales.
For the first eleven months of this year, revenues from sales decreased by 15% compared to the same period of 2014, including 2% increase of domestic sales and a 23% decrease of export sales.